1992年至1993年8月31日世界药品市场凭处方出售的药品总销售额(中国和前苏联除外)为1634亿美元,与上年度1410亿美元比较,增长8%以上,其中医院和药店分别增长9%和7%,这是多年来首次出现世界药品市场增长率为一位数的情况。美国一如既往,始终占据全球销售额之冠,但占全球市场的份额未见上升,与上年一样,仍为29%。又在前10个药品市场最大的国家中,美国的增长率通常是领先于其它国家,但在1993财政年度中,仅增长6%,低于多数国家,这与克林顿政府干预药品价格和提出修正社会健康保险法的一条措施不无关系。第二大市场日本的增长率再次低于工业平均 Total sales of medicines sold by prescription in the world pharmaceutical market from 1992 to August 31, 1993 (excluding China and the former Soviet Union) were US$163.4 billion, an increase of more than 8% compared with the previous year of US$141 billion, of which hospitals and pharmacies were separated. Growth of 9% and 7%, which is the first time in years that the world pharmaceutical market has grown at a single digit rate. The United States, as always, has consistently topped global sales, but its share in the global market has not risen. It is still 29% as in the previous year. In the top 10 countries with the largest drug market, the U.S. growth rate is usually ahead of other countries, but in the fiscal year 1993, it only increased by 6%, which is lower than most countries. This interferes with the Clinton administration’s intervention in drug prices and proposes amendments. One measure of social health insurance law is not unrelated. In the second largest market, Japan’s growth rate is lower than the industrial average again